Streetbeat News

Products Services

AMC

LYV

MAT

MSFT

SPOT

TIME magazine's shortlist for Person of the Year 2023 includes various influential figures such as Taylor Swift, Sam Altman, and Xi Jinping. The list also contains controversial choices like Vladimir Putin. Taylor Swift's success on Spotify and her Eras Tour's impact on Live Nation Entertainment and AMC Entertainment Holdings are highlighted. Sam Altman's OpenAI received significant funding from Microsoft. The Barbie movie's success is a win for Mattel. The winner will be announced by TIME on Wednesday morning.

Portfolio Pulse from Chris Katje

December 05, 2023 | 7:55 pm

BA

Boeing delivered a total of 46 narrowbody aircraft in November, including 45 737 MAX jets and 1 P-8 maritime patrol aircraft, according to a Reuters source.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 7:45 pm

ETSY

Austin Ziegler, a 27-year-old engineer, turned his Etsy Inc (NASDAQ:ETSY) 3D printing side hustle into a booming business by focusing on building strong customer reviews. Initially struggling to sell battery cases, he shifted to selling inexpensive keychains and magnets to garner reviews. This strategy paid off, leading to sales of his other products and two of his items making Etsy's bestsellers list, with one generating $10,000 in a week.

Portfolio Pulse from Adam Eckert

December 05, 2023 | 7:37 pm

BYDDY

F

TSLA

XPEV

November saw record EV sales and deliveries, with mixed results for major players. Tesla's China-made EV sales dropped by 17.8% YoY, but the company is still on track to meet its annual goal of 1.8 million deliveries. BYD set a record with 301,378 vehicle deliveries in November, a 31% increase YoY. XPeng's sales surged by 245% YoY, continuing a 10-month streak of MoM growth. Ford's overall vehicle sales dipped by 0.5%, but it achieved a record in EV sales with 8,958 units sold, boosting its shares by 1.4% during afternoon trading.

Portfolio Pulse from Upwallstreet

December 05, 2023 | 7:36 pm

APLS

BofA Securities analyst Tazeen Ahmad upgraded Apellis Pharmaceuticals (NASDAQ: APLS) to Buy from Neutral and raised the price target to $85 from $52. The upgrade is based on the strong launch trajectory of Syfovre and lower risk profile following FDA's updated label that does not include a black box warning (BBW). Ahmad sees potential for upside due to the strong demand for Syfovre, its favorable comparison to Beovu, and the potential for increased sales in the EU and among physicians who had previously halted its use. The analyst forecasts 4Q sales of $90 million and risk-adjusted peak sales of $4.1 billion, with an adjusted EPS loss of $(1.91) for FY24.

Portfolio Pulse from Nabaparna Bhattacharya

December 05, 2023 | 7:34 pm

ETH-USD

SOL-USD

The total value locked in DeFi protocols reached $49.6 billion on Dec. 5, 2023, marking a significant increase from multiyear lows in mid-October. Blast, a Layer 2 project, attracted over $700 million in deposits, with assets locked until at least March 2024. Ethereum, a key DeFi asset, rose 42% since Oct. 13, outpacing the overall DeFi market. Lido and RocketPool, liquid staking services, hold 45% of DeFi's total value. Solana-based protocols marginfi, Jito, and Marinade Finance saw TVL increases of 60-120% in the past 30 days, with institutional interest in Solana growing as evidenced by Grayscale's Solana Trust trading at an 869% premium.

Portfolio Pulse from Khyathi Dalal

December 05, 2023 | 7:32 pm

DIS

KISS has performed their final concert but will continue to 'tour' using digital avatars created by Industrial Light & Magic, a company owned by The Walt Disney Company (NYSE:DIS). These avatars were showcased at Madison Square Garden and could allow KISS to perform in multiple cities simultaneously. Industrial Light & Magic, known for its work on major film franchises, partnered with Pophouse Entertainment Group for this project, hinting at the future of live performances.

Portfolio Pulse from Chris Katje

December 05, 2023 | 7:28 pm

JNJ

Johnson & Johnson (NYSE:JNJ) anticipates 5%-6% operational sales growth for FY24, with adjusted operational EPS growth of 7.3% at the midpoint ($10.55-$10.75). The guidance includes a $0.15 dilutive impact from the Laminar, Inc. acquisition. JNJ's Innovative Medicine business aims for over 20 novel therapies and 50 product expansions by 2030, forecasting 5%-7% sales growth from 2025-2030. The MedTech business expects one-third of sales from new products by 2027. Strong demand is expected for cancer treatments Darzalex and Carvykti, and psoriasis drug Stelara. JNJ's stock is down 0.25% to $158.49.

Portfolio Pulse from Nabaparna Bhattacharya

December 05, 2023 | 7:12 pm

AAVE

Web3Auth has partnered with Safe to launch SafeAuth, a new service that aims to simplify the use of crypto wallets by using social logins instead of seed phrases. SafeAuth employs Multi-Party Computation for enhanced security and user convenience. It allows users to access over 190 dApps, including Aave, with a single smart account, promoting interoperability within the blockchain ecosystem.

Portfolio Pulse from Murtuza Merchant

December 05, 2023 | 6:52 pm

TTWO

The release of the Grand Theft Auto VI trailer before its scheduled time led to a post-market decline in Take-Two Interactive Software Inc's (NASDAQ:TTWO) shares by approximately 7%. Despite the drop, analysts remain bullish on TTWO's future, with Oppenheimer Analyst Martin Yang giving an Outperform rating and a price target of $170 based on a valuation model. Raymond James analyst Andrew Marok also maintained an Outperform rating, noting a slight delay in GTA VI's release to 2025 but maintaining a positive outlook on the game's potential success. The trailer has garnered significant attention, becoming the second most-viewed video game trailer on YouTube.

Portfolio Pulse from Franca Quarneti

December 05, 2023 | 6:50 pm